Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Showing 13 citing articles:

Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics
Nicolás J. Garrido, Félix González-Martínez, Ana M. Torres, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 722-722
Open Access
Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma
Rui Guo, Visweswara Rao Pasupuleti, Bo Liao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody
Qimeng Chang, Huarong Mao, Jin-Feng Feng, et al.
Biochemical Pharmacology (2025), pp. 116927-116927
Closed Access
Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
Tong Liu, Guorui Meng, Shihui Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting the p53-p21 Axis in Liver Cancer: Linking Cellular Senescence to Tumor Suppression and Progression
Lakshmi Thangavelu, Abdulmalik S A Altamimi, Nehmat Ghaboura, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155652-155652
Closed Access | Times Cited: 2
Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications
Yu Zhang, Weihao Xu, Chuanhui Peng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Advances in predictive biomarkers for melanoma immunotherapy
Wenjie Ma, Wanlin Liu, Jingqin Zhong, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
The role of exosomes in liver cancer: comprehensive insights from biological function to therapeutic applications
Yinghui Zhang, Congcong Zhang, Nan Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
Annapaola Montagner, Andrea Arleo, Fabrizia Suzzi, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1581-1581
Open Access | Times Cited: 1
Resistance against the development of diethylnitrosamine-induced hepatocellular carcinoma in female C3H mice: an experimental model
Daniela Romina Montagna, María Florencia Todero, Gabriela Cintia Postma, et al.
EXPERIMENTAL ANIMALS (2024) Vol. 73, Iss. 4, pp. 399-411
Open Access
The immunotherapy mechanism of Hedyotis Diffusae Herba in treating liver cancer: a study based on network pharmacology, bioinformatics, and experimental validation
Qingsheng Zheng, Xueying Wu, Shuai Peng
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Therapeutic Potential of lncRNAs in Regulating Disulfidptosis for Cancer Treatment
Abida Abida, Abdulmalik S A Altamimi, Nehmat Ghaboura, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155657-155657
Closed Access
ABCA1 promote tumor environment heterogeneity via epithelial mesenchymal transition in Huh7 and HepG2 liver cancer cell
Dinglai Yu, Fang Guo, Qiyu Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top